NEC Display Solutions of America has received clearance from the U.S. Food and Drug Administration (FDA) for its MultiSync MD211G5 monitor for use in tomosynthesis applications and digital mammography.
The 21-inch, 5-megapixel, grayscale monitor features a 1,200-to-1 contrast ratio and 500 cd/m2 of calibrated brightness. It also comes with GammaComp MD quality assurance software, the company said.
